Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Regencell Bioscience Holdings Limited RGC NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • HK • USD

SharesGrow Score
53/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Regencell Bioscience Holdings Limited (RGC) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRX, ANIP, BHHKF, COLL, COSM, CVGRF and others.

RGC has a market capitalization of $14.89B, compared to an average peer market cap of $680.77M. RGC is significantly larger than its average peer.

People Also View

PBH
PBH
Prestige Consumer Healthcare Inc.
$56.66
-0.32%
 PAHC
PAHC
Phibro Animal Health Corporation
$59.02
-0.94%
 ANIP
ANIP
ANI Pharmaceuticals, Inc.
$78.29
-0.03%
 COLL
COLL
Collegium Pharmaceutical, Inc.
$35.64
+0.06%
 PROC
PROC
Procaps Group S.A.
$1.01
+100.00%
 SSIC
SSIC
Silver Spike Investment Corp.
$10.74
+1.27%
 HEXO
HEXO
HEXO Corp.
$0.71
+2.45%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message